Apogee Therapeutics (APGE) Other Non-Current Assets (2023 - 2026)

Apogee Therapeutics (APGE) has 4 years of Other Non-Current Assets data on file, last reported at $8.5 million in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $8.5 million, up 16.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.5 million (up 16.04% YoY), and the FY2025 annual result was $8.7 million, up 1641.16% from the prior year.
• Other Non-Current Assets retreated to $8.5 million in Q1 2026 per APGE's latest filing, from $8.7 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $8.9 million in Q2 2025 and troughed at $401000.0 in Q4 2023.
• A 4-year average of $4.4 million and a median of $3.9 million in 2024 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets soared 1792.52% in 2025, then advanced 16.04% in 2026.
• A 4-year view of Other Non-Current Assets shows it stood at $401000.0 in 2023, then increased by 24.19% to $498000.0 in 2024, then soared by 1641.16% to $8.7 million in 2025, then slipped by 1.79% to $8.5 million in 2026.
• Business Quant data shows APGE's Other Non-Current Assets at $8.5 million in Q1 2026, $8.7 million in Q4 2025, and $8.7 million in Q3 2025.